Table 5.
Clopidogrel‐Naïve | On Clopidogrel | |||
---|---|---|---|---|
β | P Value | β | P Value | |
Sex | 0.30 | 0.05 | 0.38 | 0.03 |
Diabetes mellitus | 0.42 | 0.01 | 0.35 | 0.03 |
Beta blockers | 0.2 | 0.1 | 0.36 | 0.02 |
Calcium blockers | 0.28 | 0.04 | 0.2 | 0.07 |
Platelets | 0.65 | 0.001 | 0.67 | 0.0001 |
Multiple logistic regression analysis (stepwise method) performed to examine the factors related to MAKH as a categorical variable (with ≥72‐mm threshold). Nine variables were included in the logistic regression model based on the results presented in Tables 3 and 4: sex, race, diabetes, hypertension, beta blockers, calcium blockers, platelets, hemoglobin, and white blood cells. Shown in the table are only factors that were significantly associated with MAKH ≥72 mm either on or off clopidogrel treatment. Race, hypertension, hemoglobin level, and white blood cell count were not significantly associated with the frequency of MAKH ≥72 mm (P≥0.1). MAKH indicates maximum thrombin‐induced platelet‐fibrin clot strength.